Audrey Davis
Impact in
- Parasitology top 5%
- Parasites and Host Interactions
- Pharmacology top 5%
- Cholinesterase and Neurodegenerative Diseases
Papers in
- Pharmacology 12
- Cholinesterase and Neurodegenerative Diseases 11
-
- Receptor Mechanisms and Signaling 5
- Pharmacological Receptor Mechanisms and Effects 4
- Nicotinic Acetylcholine Receptors Study 3
- Co-authors
- D. R. Shackleton Bailey (2 shared papers)Patrick Dallemagne (16 shared papers)Christophe Rochais (15 shared papers)Cédric Lecoutey (10 shared papers)Jana Sopková‐de Oliveira Santos (7 shared papers)Michel Boulouard (7 shared papers)Sylvie Claeysen (7 shared papers)Sophie Corvaisier (6 shared papers)
In The Last Decade
Audrey Davis
30 papers receiving 609 citations
Peers
Comparison fields: 5 of 96
- Parasitology 77
- Pharmacology 180
- Cellular and Molecular Neuroscience 177
- Pharmaceutical Science 52
- Computational Theory and Mathematics 135
Countries citing papers authored by Audrey Davis
This map shows the geographic impact of Audrey Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Audrey Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Audrey Davis more than expected).
Fields of papers citing papers by Audrey Davis
This network shows the impact of papers produced by Audrey Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Audrey Davis. The network helps show where Audrey Davis may publish in the future.
Co-authors
The 25 scholars most cited alongside Audrey Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 84 | |
| 2 | 2020 | 64 | |
| 3 | Metrifonate in urinary schistosomiasis. | 1969 | 49 |
| 4 | 2018 | 40 | |
| 5 | 2016 | 34 | |
| 6 | 2007 | 34 | |
| 7 | 2020 | 28 | |
| 8 | Comparative trials of antimonial drugs in urinary schistosomiasis. | 1968 | 28 |
| 9 | 2020 | 26 | |
| 10 | 2013 | 22 | |
| 11 | 2019 | 22 | |
| 12 | 2019 | 21 | |
| 13 | 2020 | 19 | |
| 14 | 2024 | 19 | |
| 15 | The effect of salt medicated with diethylcarbamazine in bancroftian filariasis. | 1969 | 19 |
| 16 | 2020 | 18 | |
| 17 | 2014 | 17 | |
| 18 | Field trials of ambilhar in the treatment of urinary bilharziasis in schoolchildren. | 1966 | 15 |
| 19 | 2008 | 13 | |
| 20 | 2019 | 13 |
About Audrey Davis
Audrey Davis is a scholar working on Pharmacology, Molecular Biology, Computational Theory and Mathematics, Organic Chemistry and Cellular and Molecular Neuroscience, having authored 31 papers that have together received 648 indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (11 papers), Computational Drug Discovery Methods (10 papers), Chemical synthesis and alkaloids (6 papers), Receptor Mechanisms and Signaling (5 papers), Parasites and Host Interactions (4 papers), Pharmacological Receptor Mechanisms and Effects (4 papers), Neuropeptides and Animal Physiology (4 papers) and Nicotinic Acetylcholine Receptors Study (3 papers). The work is most often cited by research in Parasitology (77 citations), Pharmacology (180 citations), Cellular and Molecular Neuroscience (177 citations), Pharmaceutical Science (52 citations) and Computational Theory and Mathematics (135 citations). Audrey Davis has collaborated with scholars based in France, Italy and Hungary. Frequent co-authors include D. R. Shackleton Bailey, Patrick Dallemagne, Christophe Rochais, Cédric Lecoutey, Jana Sopková‐de Oliveira Santos, Michel Boulouard, Sylvie Claeysen, Sophie Corvaisier, Marc Since and Thomas Fréret. Their work appears in journals such as European Journal of Medicinal Chemistry, Molecules, Pharmaceutics, British Journal of Pharmacology and Cellular Signalling.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.